Log in
/
Register
Home
Overview
Upload / Manage Data
Browse / Search Studies
Analyze Studies
Tutorials
FAQ
Data Repository
Overview
Upload / Manage Studies
Browse / Search Studies
Analyze Studies
Data Sharing Policy
Tutorials
FAQ
Databases
Overview
Metabolite Database
Human Metabolome Gene/Protein Database (MGP)
RefMet: Reference List of Metabolite Names
External Metabolomics Databases (Links)
Protocols
Overview
General Protocols
Study-specific Protocols
Tools
Overview
Load and analyze your own dataset
Analyze Studies
MS Searches
Structure drawing
REST Service
External Tools (Links)
About
Overview
Publishing Partners
How to Cite
How to Link
Terms of Use
Personnel
Contact
Sitemap
Search
Keyword Search
Advanced Searches
Return to study ST000421 main page
Show: (1)
HMDB and KEGG pathways
(2)
REACTOME pathways
containing these metabolites
Select
Metabolite Name
Metabolite Id
Refmet Name
Ret. Index
Quant. m/z
Analysis Display
Anandamide (20:5, n-3)
ME137905
Eicosapentenoyl-EA
-
-
HILIC POSITIVE ION MODE
dodecanamide
ME138135
Dodecanamide
-
-
HILIC POSITIVE ION MODE
Linoleamide
ME139344
Linoleamide
-
-
HILIC POSITIVE ION MODE
pentanamide
ME139286
Pentanamide
-
-
HILIC POSITIVE ION MODE
12-amino-dodecanoic acid
ME141037
12-Aminododecanoic acid
-
-
Reversed phase POSITIVE ION MODE
Anandamide (18:3, n-6)
ME141351
gamma-Linolenoyl-EA
-
-
Reversed phase POSITIVE ION MODE
Anandamide (18:3, n-6) + 12.584168
ME141552
gamma-Linolenoyl-EA
-
-
Reversed phase POSITIVE ION MODE
Anandamide (18:3, n-6) + 13.313286
ME141582
gamma-Linolenoyl-EA
-
-
Reversed phase POSITIVE ION MODE
dodecanamide
ME141179
Dodecanamide
-
-
Reversed phase POSITIVE ION MODE
dodecanamide + 10.644595
ME141234
Dodecanamide
-
-
Reversed phase POSITIVE ION MODE
Linoleamide
ME141920
Linoleamide
-
-
Reversed phase POSITIVE ION MODE
(-)N-(1R-methyl-propyl) arachidonoyl amine
ME141531
N-(1R-Methyl-propyl) arachidonoyl amine
-
-
Reversed phase POSITIVE ION MODE
N-(2-hydroxyethyl)palmitamide
ME141266
Palmitoyl-EA
-
-
Reversed phase POSITIVE ION MODE
N-(2-hydroxyethyl)palmitamide + 10.900234
ME141278
Palmitoyl-EA
-
-
Reversed phase POSITIVE ION MODE
N-(2-hydroxyethyl)palmitamide + 11.029883
ME141299
Palmitoyl-EA
-
-
Reversed phase POSITIVE ION MODE
N-(2-hydroxyethyl)palmitamide + 11.126383
ME141314
Palmitoyl-EA
-
-
Reversed phase POSITIVE ION MODE
N-(2-hydroxyethyl)palmitamide + 11.2943125
ME141350
Palmitoyl-EA
-
-
Reversed phase POSITIVE ION MODE
N-(2-hydroxyethyl)palmitamide + 12.8659935
ME141553
Palmitoyl-EA
-
-
Reversed phase POSITIVE ION MODE
N-(2-hydroxyethyl)palmitamide + 14.25288
ME141690
Palmitoyl-EA
-
-
Reversed phase POSITIVE ION MODE
N-arachidonoyl D-serine
ME141119
N-Arachidonoyl D-serine
-
-
Reversed phase POSITIVE ION MODE
N-oleoylethanolamine
ME141697
Oleoyl-EA
-
-
Reversed phase POSITIVE ION MODE
octadecanamide
ME141699
Stearamide
-
-
Reversed phase POSITIVE ION MODE
UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
Terms of use
Site map
Contact
NMDR Personnel